EMA Authorised: Zonegran (zonisamide) — Amdipharm Limited

View source ↗

Summary

The European Medicines Agency authorised Zonegran (zonisamide) for partial seizures; the marketing authorisation holder is Amdipharm Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Seizures

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Status: Authorised. Therapeutic area: Epilepsies, Partial. MAH: Amdipharm Limited. Decision date: 17/09/2025